histamine h3 receptors
Recently Published Documents


TOTAL DOCUMENTS

168
(FIVE YEARS 1)

H-INDEX

35
(FIVE YEARS 0)

eLife ◽  
2020 ◽  
Vol 9 ◽  
Author(s):  
David Moreno-Delgado ◽  
Mar Puigdellívol ◽  
Estefanía Moreno ◽  
Mar Rodríguez-Ruiz ◽  
Joaquín Botta ◽  
...  

Early Huntington’s disease (HD) include over-activation of dopamine D1 receptors (D1R), producing an imbalance in dopaminergic neurotransmission and cell death. To reduce D1R over-activation, we present a strategy based on targeting complexes of D1R and histamine H3 receptors (H3R). Using an HD mouse striatal cell model and HD mouse organotypic brain slices we found that D1R-induced cell death signaling and neuronal degeneration, are mitigated by an H3R antagonist. We demonstrate that the D1R-H3R heteromer is expressed in HD mice at early but not late stages of HD, correlating with HD progression. In accordance, we found this target expressed in human control subjects and low-grade HD patients. Finally, treatment of HD mice with an H3R antagonist prevented cognitive and motor learning deficits and the loss of heteromer expression. Taken together, our results indicate that D1R - H3R heteromers play a pivotal role in dopamine signaling and represent novel targets for treating HD.


Molecules ◽  
2020 ◽  
Vol 25 (7) ◽  
pp. 1575 ◽  
Author(s):  
Alaa Alachkar ◽  
Sheikh Azimullah ◽  
Mohamed Lotfy ◽  
Ernest Adeghate ◽  
Shreesh K. Ojha ◽  
...  

Histamine H3 receptors (H3Rs) are involved in several neuropsychiatric diseases including epilepsy. Therefore, the effects of H3R antagonist E177 (5 and 10 mg/kg, intraperitoneal (i.p.)) were evaluated on the course of kindling development, kindling-induced memory deficit, oxidative stress levels (glutathione (GSH), malondialdehyde (MDA), catalase (CAT), and superoxide dismutase (SOD)), various brain neurotransmitters (histamine (HA), acetylcholine (ACh), γ-aminobutyric acid (GABA)), and glutamate (GLU), acetylcholine esterase (AChE) activity, and c-Fos protein expression in pentylenetetrazole (PTZ, 40 mg/kg) kindled rats. E177 (5 and 10 mg/kg, i.p.) significantly decreased seizure score, increased step-through latency (STL) time in inhibitory avoidance paradigm, and decreased transfer latency time (TLT) in elevated plus maze (all P < 0.05). Moreover, E177 mitigated oxidative stress by significantly increasing GSH, CAT, and SOD, and decreasing the abnormal level of MDA (all P < 0.05). Furthermore, E177 attenuated elevated levels of hippocampal AChE, GLU, and c-Fos protein expression, whereas the decreased hippocampal levels of HA and ACh were modulated in PTZ-kindled animals (all P < 0.05). The findings suggest the potential of H3R antagonist E177 as adjuvant to antiepileptic drugs with an added advantage of preventing cognitive impairment, highlighting the H3Rs as a potential target for the therapeutic management of epilepsy with accompanied memory deficits.


Author(s):  
Tamara Coslovich ◽  
Alberto Della Mora ◽  
Giuseppe D’Angelo ◽  
Fulvia Ortolani ◽  
Giuliano Taccola

Synapse ◽  
2019 ◽  
Vol 73 (7) ◽  
pp. e22096
Author(s):  
Christine M. Sandiego ◽  
Olivier Barret ◽  
Hsiaoju Lee ◽  
David Alagille ◽  
Amy Amenta ◽  
...  

2018 ◽  
Vol 15 (1) ◽  
pp. 85-93
Author(s):  
Guadalupe-Elide Morales-Figueroa ◽  
Nayeli Rivera-Ramírez ◽  
Raúl González-Pantoja ◽  
Juan Escamilla-Sánchez ◽  
Ubaldo García-Hernández ◽  
...  

2017 ◽  
Vol 22 (1) ◽  
pp. 127-141 ◽  
Author(s):  
T. Chaumette ◽  
E. Chapuy ◽  
E. Berrocoso ◽  
M. Llorca-Torralba ◽  
L. Bravo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document